Literature DB >> 29241781

Nifedipine cream versus sildenafil cream for patients with secondary Raynaud phenomenon: A randomized, double-blind, controlled pilot study.

Ximena Wortsman1, Pablo Del Barrio-Díaz2, Rodrigo Meza-Romero3, Christine Poehls-Risco3, Cristián Vera-Kellet4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29241781     DOI： 10.1016/j.jaad.2017.08.018

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  Possible benefit of tadalafil cream for the treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis.

Authors:  Andreu Fernández-Codina; Mikameh Kazem; Janet E Pope
Journal:  Clin Rheumatol       Date:  2020-02-03       Impact factor: 2.980

Review 2.  Raynaud's phenomenon.

Authors:  Ariane L Herrick
Journal:  J Scleroderma Relat Disord       Date:  2019-02-13

Review 3.  Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.

Authors:  George S Baillie; Gonzalo S Tejeda; Michy P Kelly
Journal:  Nat Rev Drug Discov       Date:  2019-08-06       Impact factor: 84.694

4.  Pharmacotherapy Options in the Management of Raynaud's Phenomenon.

Authors:  Alicia M Hinze; Fredrick M Wigley
Journal:  Curr Treatm Opt Rheumatol       Date:  2018-07-04

Review 5.  Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease.

Authors:  Nikolaos Tzoumas; Tariq E Farrah; Neeraj Dhaun; David J Webb
Journal:  Br J Pharmacol       Date:  2020-02-04       Impact factor: 8.739

Review 6.  Raynaud's Phenomenon with Focus on Systemic Sclerosis.

Authors:  Magdalena Maciejewska; Mariusz Sikora; Cezary Maciejewski; Rosanna Alda-Malicka; Joanna Czuwara; Lidia Rudnicka
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.